Septerna, Inc. Common Stock SEPN
Analyst Ratings
- Consensus
- Buy — 7 Buy · 0 Hold · 0 Sell (7 analysts)
- Avg. Price Target
- $52.43 (+19.2% upside)
Key Stats
- Today's Range
- $43.68 – $45.43
- 50-Day Range
- $34.36 – $45.60
- 52-Week Range
- $16.65 – $51.10
- Volume
- 223K shs
- Average Volume
- 374K shs
- Market Cap
- $2.05 billion
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.94%
- Days to Cover
- 1.19
About Septerna, Inc. Common Stock
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.
Related Stocks
Compare head-to-head: SEPN vs LLY·SEPN vs JNJ·SEPN vs ABBV·SEPN vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.